DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional Classification
Modern Pathology · 2024-12 · 37 (12) · 100625
DOI: 10.1016/j.modpat.2024.100625 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2024-12. Verfasst von Philipp Jurmeister und 30 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, and German Can…. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms, DNA Methylation, Biomarkers, Tumor. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Illumina Inc.
Abstract (Originalsprache)
Tumors of the major and minor salivary glands histologically encompass a diverse and partly overlapping spectrum of frequent diagnostically challenging neoplasms. Despite recent advances in molecular testing and the identification of tumor-specific mutations or gene fusions, there is an unmet need to identify additional diagnostic biomarkers for entities lacking specific alterations. In this study, we collected a comprehensive cohort of 363 cases encompassing 20 different salivary gland tumor entities and explored the potential of DNA methylation to classify these tumors. We were able to show that most entities show specific epigenetic signatures and present a machine learning algorithm that achieved a mean balanced accuracy of 0.991. Of note, we showed that cribriform adenocarcinoma is epigenetically distinct from classical polymorphous adenocarcinoma, which could support risk stratification of these tumors. Myoepithelioma and pleomorphic adenoma form a uniform epigenetic class, supporting the theory of a single entity with a broad but continuous morphologic spectrum. Furthermore, we identified a histomorphologically heterogeneous but epigenetically distinct class that could represent a novel tumor entity. In conclusion, our study provides a comprehensive resource of the DNA methylation landscape of salivary gland tumors. Our data provide novel insight into disputed entities and show the potential of DNA methylation to identify new tumor classes. Furthermore, in future, our machine learning classifier could support the histopathologic diagnosis of salivary gland tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: P…
- Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany.
- Institute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
- Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
- German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany; Institute of Neuropathology, Ludwig-Maximilians-Universität München, Munich, Germany.
- Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Förderung
- Illumina Inc
Zitieren
APA
Jurmeister, P., Leitheiser, M., Arnold, A., Capilla, E. P., Mochmann, L. H., Zhdanovic, Y., Schleich, K., Jung, N., Chimal, E. C., Jung, A., Kumbrink, J., Harter, P., Prenißl, N., Elezkurtaj, S., Brcic, L., Deigendesch, N., Frank, S., Hench, J., Försch, S., …, & Ihrler, S. (2024). DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional Classification. Modern Pathology, 37(12), 100625. https://doi.org/10.1016/j.modpat.2024.100625
Vancouver
Jurmeister P, Leitheiser M, Arnold A, Capilla EP, Mochmann LH, Zhdanovic Y, et al. DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional Classification. Modern Pathology. 2024;37(12):100625. doi:10.1016/j.modpat.2024.100625
BibTeX
@article{Jurmeister2024,
author = {Jurmeister, Philipp and Leitheiser, Maximilian and Arnold, Alexander and Capilla, Emma Payá and Mochmann, Liliana H and Zhdanovic, Yauheniya and Schleich, Konstanze and Jung, Nina and Chimal, Edgar Calderon and Jung, Andreas and Kumbrink, Jörg and Harter, Patrick and Prenißl, Niklas and Elezkurtaj, Sefer and Brcic, Luka and Deigendesch, Nikolaus and Frank, Stephan and Hench, Jürgen and Försch, Sebastian and Breimer, Gerben and van Engen van Grunsven, Ilse and Lassche, Gerben and van Herpen, Carla and Zhou, Fang and Snuderl, Matija and Agaimy, Abbas and Müller, Klaus-Robert and von Deimling, Andreas and Capper, David and Klauschen, Frederick and Ihrler, Stephan},
title = {DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional Classification},
journal = {Modern Pathology},
year = {2024},
volume = {37},
number = {12},
pages = {100625},
doi = {10.1016/j.modpat.2024.100625}
}
EUVIMED